During the past decade, Akdeniz University Medical Faculty conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 20 clinical trials were completed, i.e. on average, 37% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 13 clinical trials were completed. i.e. 41.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Akdeniz University Medical Faculty" #1 sponsor was "Hoffmann-La Roche" with 17 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored and "AstraZeneca Turkey" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Akdeniz University Medical Faculty" #1 collaborator was "Klinar CRO" with 3 trials as a collaborator, "Ankara University" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator and "CenTrial GmbH" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Akdeniz University Medical Faculty" are "Breast Cancer" (5 trials), "Arthritis, Psoriatic" (3 trials), "Breast Neoplasms" (3 trials), "Hemophilia A" (3 trials) and "Idiopathic Pulmonary Fibrosis" (3 trials). Many other conditions were trialed in "Akdeniz University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Akdeniz University Medical Faculty" are "Drug" (47 trials), "Other" (10 trials), "Biological" (5 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Cisplatin" (5 trials), "Docetaxel" (5 trials), "Capecitabine" (4 trials) and "Cyclophosphamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Akdeniz University Medical Faculty" are 58 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Akdeniz University Medical Faculty". undefined are not yet recruiting, 12 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Akdeniz University Medical Faculty, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Akdeniz University Medical Faculty, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".